miRNA (3 duplex)

[{"image":"https://icons.cdn.biorender.com/w75xh75/5e7cae6faa46cb0028b0e4fc/5e7cae21aa46cb0028b0e4ec.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7cae6faa46cb0028b0e4fc/5e7cae21aa46cb0028b0e4ec.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7cae6faa46cb0028b0e4fb/5e7cae21aa46cb0028b0e4ec.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7cae6faa46cb0028b0e4fb/5e7cae21aa46cb0028b0e4ec.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7cae6faa46cb0028b0e4fa/5e7cae21aa46cb0028b0e4ec.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7cae6faa46cb0028b0e4fa/5e7cae21aa46cb0028b0e4ec.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7cae6faa46cb0028b0e4f9/5e7cae21aa46cb0028b0e4ec.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7cae6faa46cb0028b0e4f9/5e7cae21aa46cb0028b0e4ec.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7cae6faa46cb0028b0e4f8/5e7cae21aa46cb0028b0e4ec.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7cae6faa46cb0028b0e4f8/5e7cae21aa46cb0028b0e4ec.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7cae6faa46cb0028b0e4f7/5e7cae21aa46cb0028b0e4ec.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7cae6faa46cb0028b0e4f7/5e7cae21aa46cb0028b0e4ec.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7cae6faa46cb0028b0e4f6/5e7cae21aa46cb0028b0e4ec.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7cae6faa46cb0028b0e4f6/5e7cae21aa46cb0028b0e4ec.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7cae6faa46cb0028b0e4f5/5e7cae21aa46cb0028b0e4ec.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7cae6faa46cb0028b0e4f5/5e7cae21aa46cb0028b0e4ec.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7cae6faa46cb0028b0e4f4/5e7cae21aa46cb0028b0e4ec.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7cae6faa46cb0028b0e4f4/5e7cae21aa46cb0028b0e4ec.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7cae6faa46cb0028b0e4f3/5e7cae21aa46cb0028b0e4ec.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7cae6faa46cb0028b0e4f3/5e7cae21aa46cb0028b0e4ec.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7cae6faa46cb0028b0e4f2/5e7cae21aa46cb0028b0e4ec.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7cae6faa46cb0028b0e4f2/5e7cae21aa46cb0028b0e4ec.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7cae6faa46cb0028b0e4f1/5e7cae21aa46cb0028b0e4ec.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7cae6faa46cb0028b0e4f1/5e7cae21aa46cb0028b0e4ec.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7cae6faa46cb0028b0e4f0/5e7cae21aa46cb0028b0e4ec.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7cae6faa46cb0028b0e4f0/5e7cae21aa46cb0028b0e4ec.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7cae6faa46cb0028b0e4ef/5e7cae21aa46cb0028b0e4ec.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7cae6faa46cb0028b0e4ef/5e7cae21aa46cb0028b0e4ec.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7cae6faa46cb0028b0e4ee/5e7cae21aa46cb0028b0e4ec.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7cae6faa46cb0028b0e4ee/5e7cae21aa46cb0028b0e4ec.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e7cae6faa46cb0028b0e4ed/5e7cae21aa46cb0028b0e4ec.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e7cae6faa46cb0028b0e4ed/5e7cae21aa46cb0028b0e4ec.png"}]